Article Versions Notes

Szymanska E, Dadalski M, Sieczkowska-Golub J, Jarzebicka D, Meglicka M, Osiecki M, Wiernicka A, Lebensztejn DM, Korczowski B, Kierkus J. Premedication Does Not Influence the Incidence of Infliximab Infusion Reactions in Pediatric Patients with Inflammatory Bowel Disease—A Single Center Case–Control Study. Journal of Clinical Medicine. 2021; 10(14):3177. https://doi.org/10.3390/jcm10143177

Szymanska, Edyta, Maciej Dadalski, Joanna Sieczkowska-Golub, Dorota Jarzebicka, Monika Meglicka, Marcin Osiecki, Anna Wiernicka, Dariusz M. Lebensztejn, Bartosz Korczowski, and Jaroslaw Kierkus. 2021. "Premedication Does Not Influence the Incidence of Infliximab Infusion Reactions in Pediatric Patients with Inflammatory Bowel Disease—A Single Center Case–Control Study" Journal of Clinical Medicine 10, no. 14: 3177. https://doi.org/10.3390/jcm10143177

Szymanska, E., Dadalski, M., Sieczkowska-Golub, J., Jarzebicka, D., Meglicka, M., Osiecki, M., Wiernicka, A., Lebensztejn, D. M., Korczowski, B., & Kierkus, J. (2021). Premedication Does Not Influence the Incidence of Infliximab Infusion Reactions in Pediatric Patients with Inflammatory Bowel Disease—A Single Center Case–Control Study. Journal of Clinical Medicine, 10(14), 3177. https://doi.org/10.3390/jcm10143177